Top Suppliers:I want be here


1092443-52-1

1092443-52-1 structure
1092443-52-1 structure
  • Name: BS-181
  • Chemical Name: 5-N-(6-aminohexyl)-7-N-benzyl-3-propan-2-ylpyrazolo[1,5-a]pyrimidine-5,7-diamine,hydrochloride
  • CAS Number: 1092443-52-1
  • Molecular Formula: C22H32N6
  • Molecular Weight: 380.53
  • Catalog: Research Areas Cancer
  • Create Date: 2018-12-25 10:15:42
  • Modify Date: 2024-01-02 22:41:16
  • BS-181 is a highly selective CDK7 inhibitor with an IC50 of 21 nM, showing 40-fold selective over CDK1, 2, 4, 5, 6, or 9.

Name 5-N-(6-aminohexyl)-7-N-benzyl-3-propan-2-ylpyrazolo[1,5-a]pyrimidine-5,7-diamine,hydrochloride
Synonyms BS181
N-(6-Aminohexyl)-N-benzyl-3-isopropylpyrazolo[1,5-a]pyrimidine-5,7-diamine hydrochloride (1:1)
Pyrazolo[1,5-a]pyrimidine-5,7-diamine, N-(6-aminohexyl)-3-(1-methylethyl)-N-(phenylmethyl)-, hydrochloride (1:1)
BS-181 HCl
N5-(6-aminohexyl)-N7-benzyl-3-iso-propylpyrazolo[1,5-a]pyrimidine-5,7-diamine
BS-181 hydrochloride
BS-181
Description BS-181 is a highly selective CDK7 inhibitor with an IC50 of 21 nM, showing 40-fold selective over CDK1, 2, 4, 5, 6, or 9.
Related Catalog
Target

CDK7/CycH/MAT1:0.021 μM (IC50)

CDK2/Cyc E:0.88 μM (IC50)

CDK1/cycB:8.1 μM (IC50)

CDK4/Cyc D1:33 μM (IC50)

CDK5/p35NCK:3 μM (IC50)

CDK6/cycD1:47 μM (IC50)

CDK9/cycT:4.2 μM (IC50)

In Vitro BS-181 promotes cell cycle arrest and inhibits cancer cell growth, and growth is inhibited for all cell lines tested, with IC50 values ranging from 11.5 to 37 μM. BS-181 inhibits RB phosphorylation at Ser795 and Ser821 with an apparent IC50 of 15 μM, similar to the IC50 obtained for P-Ser2 inhibition. BS-181 treatment of MCF-7 cells leads to G1 arrest at and apoptosis[1]. BS-181 inhibits GC cell and normal gastric epithelial RGM-1 cell line growth with inhibitory concentration (IC50) ranging from 17 to 22 μM and 6.5 μM, respectively. BS-181 significantly inhibits cell migration and invasion ability in a dose-dependent manner[2].
In Vivo BS-181 (5 mg/kg, 10 mg/kg, i.p.) inhibits the growth of MCF-7 tumors in nude mice. Intravenous (i.v) and i.p administration of 10 mg/kg BS-181 shows rapid clearance[1]. BS-181 (10 mg/kg/d or 20 mg/kg/d, i.p.) significantly inhibits the growth of tumor in a dose-dependent manner compared to the control group[2].
Cell Assay Cell viability is detected using Cell Counting Kit (CCK-8 kit) according to supplier’s introductions. Briefly, BGC823 cells are seeded at 104 cells per well for 48 hours with or without BS-181. Then, the absorbance is detected at 450 nm (reference at 650 nm) in each well.
Animal Admin In total, 5×106 BGC823 cells (0.1 mL) are injected subcutaneously into the flank of the mice. Tumor measurements are performed two times per week, and volumes are calculated using the formula: tumor size=(length [mm] × width2 [mm])/2. Finally, 30 mice (tumor volume 100-200 mm3) are selected and randomLy assigned into three groups. As previously described, BS-181 is prepared in 10% dimethyl sulfoxide/50 mM HCl/5% Tween 20/85% saline. Micereceive BS-181 injection (ip) twice daily at indicated doses (BS-181 [10 mg/kg/d or 20 mg/kg/d] or roscovitine [20 mg/kg/d]) for a total of 14 days. Control mice are injected with vehicles. Animal weights and tumor volume are measured each day throughout the 14-day treatment. In addition, all rats are kept for another 30 days for survival observation. Mice are injected intraperitoneally twice daily with BS-181 at 5 mg/kg or 10 mg/kg.
References

[1]. Ali S et al. The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity. Cancer Res. 2009 Aug 1;69(15):6208-15.

[2]. Wang BY, et al. Selective CDK7 inhibition with BS-181 suppresses cell proliferation and induces cell cycle arrest and apoptosis in gastric cancer. Drug Des Devel Ther. 2016 Mar 16;10:1181-9.

Molecular Formula C22H32N6
Molecular Weight 380.53
PSA 80.27000
LogP 6.04410
Storage condition 2-8℃